Idris Firman, Sinclair Andrew H, Ayers Katie L
The Murdoch Children's Research Institute, Melbourne, Australia.
The Department of Paediatrics, University of Melbourne, Melbourne, Australia.
Andrology. 2025 Jul;13(5):1025-1043. doi: 10.1111/andr.13708. Epub 2024 Jul 31.
Differences/disorders of sex development can be caused by disruptions to the molecular and cellular mechanisms that control development and sex determination of the reproductive organs with 1:100 live births affected. Multiple genes are associated with 46, XY differences/disorders of sex development that can cause varying clinical phenotypes. An accurate genetic diagnosis is essential to guide clinical care for individuals with 46, XY differences/disorders of sex development and can contribute to family planning. The use of genomics in differences/disorders of sex development has grown, with several advances employed in genetic diagnosis; however, diagnostic rates have stagnated at less than 50% for these conditions. This review will discuss 46, XY differences/disorders of sex development, its molecular causes, and the genomic technologies currently utilized for diagnosis with focus on reports from the last 5 years. We also touch on the challenges in diagnosing 46, XY differences/disorders of sex development and discuss new and future technologies that promise to improved diagnostic rates for these difficult conditions.
性发育差异/障碍可由控制生殖器官发育和性别决定的分子和细胞机制受到干扰引起,每100例活产中有1例受影响。多个基因与46,XY性发育差异/障碍相关,可导致不同的临床表型。准确的基因诊断对于指导46,XY性发育差异/障碍患者的临床护理至关重要,并且有助于计划生育。基因组学在性发育差异/障碍中的应用有所增加,在基因诊断中采用了多项进展;然而,这些病症的诊断率停滞在不到50%。本综述将讨论46,XY性发育差异/障碍、其分子原因以及目前用于诊断的基因组技术,重点关注过去5年的报告。我们还将探讨诊断46,XY性发育差异/障碍的挑战,并讨论有望提高这些疑难病症诊断率的新技术和未来技术。